<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05066659</url>
  </required_header>
  <id_info>
    <org_study_id>YM110122F</org_study_id>
    <nct_id>NCT05066659</nct_id>
  </id_info>
  <brief_title>Balance Performance and Corticomotor Inhibition in PD</brief_title>
  <official_title>Relationship Between Balance Performance and Corticomotor Inhibition in Individuals With Parkinsons' Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Yang Ming University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Yang Ming University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postural instability is one of the motor features of Parkinson's disease (PD). Most patients&#xD;
      will develop balance dysfunction, and they may get worse with disease progression. According&#xD;
      to previous studies, people with PD had abnormal changes in corticomotor excitability,&#xD;
      especially disinhibition in the primary motor cortex (M1). Some evidence had shown that the&#xD;
      cortical function in the M1 is crucial for the pathophysiology of the underlying motor&#xD;
      symptoms in PD. Furthermore, neurostimulation over the M1 could modulate the corticomotor&#xD;
      excitability in individuals with PD, and then improve their motor and also balance&#xD;
      performance. However, whether the impaired corticomotor inhibition relates to balance&#xD;
      dysfunction in people with PD is still unknown. In this study, the purpose is to investigate&#xD;
      the possible relationship between corticomotor inhibition and balance performance in&#xD;
      individuals with PD. However, the postural position during TMS measurement may affect the&#xD;
      corticomotor excitability. To further establish the above-mentioned relationship, the&#xD;
      secondary purpose is to explore and confirm whether the postural position will influence the&#xD;
      correlation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 8, 2021</start_date>
  <completion_date type="Anticipated">September 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intracortical inhibition</measure>
    <time_frame>20 minutes</time_frame>
    <description>Short-interval intracortical inhibition assessed by transcranial magnetic stimulation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corticospinal inhibition</measure>
    <time_frame>20 minutes</time_frame>
    <description>Cortical silent period assessed by transcranial magnetic stimulation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Static balance</measure>
    <time_frame>3 minutes</time_frame>
    <description>Sharpened Romberg test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dynamic balance</measure>
    <time_frame>5 minutes</time_frame>
    <description>Functional reach test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional balance</measure>
    <time_frame>15 minutes</time_frame>
    <description>Mini-Balance Evaluation Systems Test</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Parkinson Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        people with Parkinson's disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  the Hoehn and Yahr stage between 1 and 3&#xD;
&#xD;
          -  age 40 to 80 years&#xD;
&#xD;
          -  a stable treatment of anti-PD medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any contraindications of TMS&#xD;
&#xD;
          -  any injury histories or disorders affecting balance&#xD;
&#xD;
          -  any neurosurgery experience&#xD;
&#xD;
          -  neurologic conditions other than PD&#xD;
&#xD;
          -  the Mini-mental State Examination (MMSE) score &lt; 24&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yea-Ru Yang, PhD</last_name>
    <phone>886228267279</phone>
    <email>yryang@nycu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University</name>
      <address>
        <city>Taipei</city>
        <zip>112</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Yea-Ru Yang, PhD</last_name>
      <phone>886228267279</phone>
      <email>yryang@nycu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Yang Ming University</investigator_affiliation>
    <investigator_full_name>Yea-Ru Yang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease; Transcranial magnetic stimulation; Motor cortex; Corticomotor inhibition; Balance performance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

